Accuray (ARAY) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,615.00 |
| Dec 31, 2025 | -6,044.00 |
| Sep 30, 2025 | -3,780.00 |
| Jun 30, 2025 | 97.00 |
| Mar 31, 2025 | 2,682.00 |
| Dec 31, 2024 | 575.00 |
| Sep 30, 2024 | -1,972.00 |
| Jun 30, 2024 | 195.00 |
| Mar 31, 2024 | -148.00 |
| Dec 31, 2023 | 2,568.00 |
| Sep 30, 2023 | 5,956.00 |
| Jun 30, 2023 | 2,365.00 |
| Mar 31, 2023 | 2,335.00 |
| Dec 31, 2022 | 2,106.00 |
| Sep 30, 2022 | 2,665.00 |
| Jun 30, 2022 | 4,373.00 |
| Mar 31, 2022 | 4,687.00 |
| Dec 31, 2021 | 4,736.00 |
| Sep 30, 2021 | 12,235.00 |
| Jun 30, 2021 | 7,950.00 |
| Mar 31, 2021 | 4,144.00 |
| Dec 31, 2020 | 5,204.00 |
| Sep 30, 2020 | 4,039.00 |
| Jun 30, 2020 | 1,022.00 |
| Mar 31, 2020 | 1,173.00 |
| Dec 31, 2019 | 1,011.00 |
| Sep 30, 2019 | 712.00 |
| Jun 30, 2019 | 613.00 |
| Mar 31, 2019 | -679.00 |
| Dec 31, 2018 | -205.00 |
| Sep 30, 2018 | 484.00 |
| Jun 30, 2018 | 815.00 |
| Mar 31, 2018 | 1,556.00 |
| Dec 31, 2017 | 1,412.00 |
| Sep 30, 2017 | 496.00 |
| Jun 30, 2017 | 63.00 |
| Mar 31, 2017 | 617.00 |
| Dec 31, 2016 | 1,203.00 |
| Sep 30, 2016 | 1,246.00 |